Related Experiment Video

Updated: Aug 23, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Advances in the development of therapeutic nucleic acids against cervical cancer

Joseph A DiPaolo1, Luis M Alvarez-Salas

  • 1Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20894, USA. jd81a@nih.gov

Expert Opinion on Biological Therapy
|July 23, 2004
PubMed

Insights

Therapeutic nucleic acids (TNAs) show promise in treating cervical cancer by targeting high-risk human papillomaviruses (HPVs). These TNAs, including antisense oligodeoxyribonucleotides and RNA interference, inhibit tumor growth and offer new treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Cervical cancer is a major global health concern for women.
  • High-risk human papillomaviruses (HPVs) E6/E7 genes are the primary cause of cervical cancer.
  • HPV E6/E7 genes are ideal targets for therapeutic nucleic acids (TNAs).

Purpose of the Study:

  • To review the role of TNAs in cervical cancer treatment.
  • To highlight the potential of various TNAs, including antisense oligodeoxyribonucleotides (AS-ODNs), ribozymes (RZs), and RNA interference (RNAi) via small interfering RNA (siRNA).
  • To discuss the future prospects of TNAs in managing cervical cancer.

Main Methods:

  • Review of basic, clinical, and epidemiological analyses on HPV and cervical cancer.
  • Examination of TNA mechanisms, including AS-ODNs, RZs, and siRNA.
  • Discussion of TNA efficacy in inhibiting HPV E6/E7 gene expression and tumor growth.

Main Results:

  • AS-ODNs and RZs effectively inhibit in vivo tumor growth by targeting HPV-16 and HPV-18 E6/E7 transcripts.
  • RNAi, induced by siRNA, shows potential as an effective TNA for cervical cancer.
  • Multiple RZs can abrogate highly variable HPVs.
  • siRNA and aptamers are identified as key TNAs for cervical cancer treatment.

Conclusions:

  • TNAs represent a promising therapeutic strategy for cervical cancer.
  • Ongoing clinical trials will determine the preventive and therapeutic roles of TNAs.
  • TNAs aim to control tumor growth, reduce tumor mass, prevent metastasis, and enhance immune interactions in cervical cancer management.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.